Clinical outcomes of dupilumab therapy in chronic rhinosinusitis with nasal polyps in a Canadian tertiary care rhinology practice

[1]  M. Bonini,et al.  Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment , 2022, Journal of clinical medicine.

[2]  S. Kilty,et al.  Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps , 2022, Journal of Otolaryngology - Head & Neck Surgery.

[3]  L. Rudmik,et al.  Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps , 2021, International forum of allergy & rhinology.

[4]  N. Bhattacharyya,et al.  Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease: a case series. , 2021, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  Philip G. Chen,et al.  The predictive utility of the 22‐item sino‐nasal outcome test (SNOT‐22): A scoping review , 2021, International forum of allergy & rhinology.

[6]  C. Bachert,et al.  Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP. , 2021, Rhinology.

[7]  B. Rotenberg,et al.  Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis , 2021, Journal of Otolaryngology - Head & Neck Surgery.

[8]  C. Bachert,et al.  Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps , 2021, International forum of allergy & rhinology.

[9]  S. Fujieda,et al.  The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan , 2020, The Laryngoscope.

[10]  J. Sykes,et al.  Surgical outcomes in aspirin‐exacerbated respiratory disease without aspirin desensitization , 2020, International forum of allergy & rhinology.

[11]  M. Shrime,et al.  Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps , 2020, The Laryngoscope.

[12]  C. Bachert,et al.  Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials , 2019, The Lancet.

[13]  Kristine A. Smith,et al.  Long‐term revision rates for endoscopic sinus surgery , 2018, International forum of allergy & rhinology.

[14]  A. Peters,et al.  Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. , 2017, The journal of allergy and clinical immunology. In practice.

[15]  C. Bachert,et al.  Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. , 2016, The Journal of allergy and clinical immunology.

[16]  M. Citardi,et al.  Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes , 2016, International forum of allergy & rhinology.

[17]  R. Rosenfeld,et al.  Clinical Practice Guideline (Update): Adult Sinusitis , 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[18]  M. Citardi,et al.  Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis , 2013, The Laryngoscope.

[19]  L. Rudmik,et al.  Cost of outpatient endoscopic sinus surgery from the perspective of the Canadian government: a time‐driven activity‐based costing approach , 2013, International forum of allergy & rhinology.

[20]  Joseph K. Han,et al.  Subclassification of chronic rhinosinusitis , 2013, The Laryngoscope.

[21]  B. Rotenberg,et al.  Revision Rates after Endoscopic Sinus Surgery: A Recurrence Analysis , 2011, The Annals of otology, rhinology, and laryngology.

[22]  V. Lund,et al.  Psychometric validity of the 22‐item Sinonasal Outcome Test , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[23]  R. Sindwani.  Clinical practice guideline: adult sinusitis , 2008 .

[24]  C. Bachert,et al.  Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. , 2001, The Journal of allergy and clinical immunology.

[25]  J. Kaprio,et al.  Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. , 1999, International journal of epidemiology.

[26]  G. Settipane,et al.  Nasal polyps in asthma and rhinitis. A review of 6,037 patients. , 1977, The Journal of allergy and clinical immunology.